Potential interventions for HIV/AIDS wasting: an overview.
Although the HIV wasting syndrome has become a far less common manifestation of advanced disease since the introduction of highly active therapies, much has been learned about a number of potential therapeutic interventions. HIV wasting therapies are reviewed. The evaluation of some of these treatments for management of body habitus alterations associated with antiretroviral therapies may be appropriate.
Abrams
D I
DI
Positive Health Program, San Francisco General Hospital, University of California, 94110, USA. dabrams@sfaids.ucsf.edu
D045930:Anabolic Agents / Q000627:therapeutic use*; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D019167:Appetite Stimulants / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D019247:HIV Wasting Syndrome / Q000188:drug therapy*; D006801:Humans; D008297:Male; D013792:Thalidomide / Q000627:therapeutic use*
D045930:Anabolic Agents; D019380:Anti-HIV Agents; D019167:Appetite Stimulants; D013792:Thalidomide